“…PPARα is a promising therapeutic target for several neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, Huntington disease and amyotrophic lateral sclerosis (Agarwal et al ., 2017; Barbiero et al ., ; D'Orio et al ., ). PPARα activation significantly decreased neuronal death in models of cerebral ischaemia reperfusion and also improved the learning and memory of rodents (Gao and Li, ; Roy et al ., ; Roy et al ., ; Xuan et al ., ). PPARα has been closely implicated in oxidative stress, neuroinflammation, neurogenesis and synaptic plasticity (Gao and Li, ; Roy et al ., ; Fidaleo et al ., ; Pérez‐Martín et al ., ).…”